KEMOCARB

This brand name is authorized in Hong Kong, Singapore, South Africa

Active ingredients

The drug KEMOCARB contains one active pharmaceutical ingredient (API):

1 Carboplatin UNII BG3F62OND5 - CARBOPLATIN

Carboplatin interferes with DNA intrastrand and interstrand crosslinks in cells exposed to the drug. DNA reactivity has been correlated with cytotoxicity. Read about Carboplatin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
KEMOCARB Concentrate for solution for infusion	Health Sciences Authority (SG)	MPI, Generic

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XA02	Carboplatin	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XA Platinum compounds
Discover more medicines within L01XA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 59532, 60146
Country: SG	Health Sciences Authority	Identifier(s): 13151P
Country: ZA	Health Products Regulatory Authority	Identifier(s): A38/26/0532, A38/26/0533